Epstein Secrets

ers include former Secretary of State Condoleezza Rice, former National Security Advisor John Bolon; U.

sury, industry and business leaders, thought leaders in think tanks and academe, and journalists. Day one speakers include former Secretary of State Condoleezza Rice, former National Security Advisor John Bolon; U.S. Ambassador to the U.N. Kelly Craft, and Australian Prime Minister Scott Morrison; 8:00 AM * CDC

s://www.reuters.com/article/us-health-coronavirus-treatments-antibod/next-big-covid-19-treatment-may-be- manufactured-antibodies-idUSKBN2421DY> (8/3, Beasley) reports, "As the world awaits a COVID-I9 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically

ury, industry and business leaders, thought leaders in think tanks and academe, and journalists. Day one speakers include former Secretary of State Condoleezza Rice, former National Security Advisor John Bolon; U.S. Ambassador to the U.N. Kelly Craft, and Australian Prime Minister Scott Morrison; 8:00 AM • CDC

rs include former Secretary of State Condoleezza Rice, former National Security Advisor John Bolon; U.S

RN- TVVi Nashville, TN (8/3, 24K), and WXIA-TVVI Atlanta (8/3, 100K). Monoclonal Antibodies Could Be "Next Big Advance" In Treatment. Reuters (8/3, Beasley) reports, "As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically

ury, industry and business leaders, thought leaders in think tanks and academe, and journalists. Day one speakers include former Secretary of State Condoleezza Rice, former National Security Advisor John Bolon; U.S. Ambassador to the U.N. Kelly Craft, and Australian Prime Minister Scott Morrison; 8:00 AM • CDC

rs include former Secretary of State Condoleezza Rice, former National Security Advisor John Bolon; U.S

RN- TVVi Nashville, TN (8/3, 24K), and WXIA-TVVI Atlanta (8/3, 100K). Monoclonal Antibodies Could Be "Next Big Advance" In Treatment. Reuters (8/3, Beasley) reports, "As the world awaits a COVID-19 vaccine, the next big advance in battling the pandemic could come from...antibodies designed specifically

USA Today <https://www.usatoday.corn/story/news/nation/2020/11/12/reducing-greenhouse-gas-emissions-stop- climate-change-study/3761882001/> (11/12, Rice, 10.31M) reports, "Even if human-caused greenhouse gas emissions can be reduced to zero, global temperatures may continue to rise for centuries afte

ters <https://www.reuters.corn/article/us-health-coronavirus-fatality/covid-19-fatality-rate-down-30-since- april-study-finds-idUSICBN27S39D> (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

e market." USA Today <https://www.usatoday.com/story/news/health/2020/10/22/fda-approves-remdesivir-covid-19- hospital-patients/3733648001/> (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. The New York

reuters.com/article/us-health-coronavirus-gilead/gileads-remdesivir-gets-u-s-fda-approval- for-hospitalized-covid-19-patients-idUSICBN2772XQ> (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

unding for organizations promoting equality." Researchers Conclude World "Already Past A Point Of No Return For Global Warming." USA Today (11/12, Rice, 10.31M) reports, "Even if human-caused greenhouse gas emissions can be reduced to zero, global temperatures may continue to rise for centuries afte

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

solidify its position as a go-to medicine for Covid-19 patients even as other drugs for the disease begin to reach the market." USA Today (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey said the drug has approvals or authorizations in around 50 countries. EFTA00148471

though the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Reuters (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-

unding for organizations promoting equality." Researchers Conclude World "Already Past A Point Of No Return For Global Warming." USA Today (11/12, Rice, 10.31M) reports, "Even if human-caused greenhouse gas emissions can be reduced to zero, global temperatures may continue to rise for centuries afte

eatments and the increased share of cases among young people, who are more likely than older ones to survive a bout with COVID-19." Reuters (11/12, Beasley) reports, "The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researc

solidify its position as a go-to medicine for Covid-19 patients even as other drugs for the disease begin to reach the market." USA Today (10/22, Rice, 10.31M) reports that Gilead Chief Medical Officer Merdad Parsey EFTA00135821 said the drug has approvals or authorizations in around 50 countries

ough the FDA "will still allow the drug's use in certain cases under its previous emergency authorization" for patients under 12. Retiterc (10/22, Beasley) reports that despite positive results from NIH and the new approval, "the World Health Organization (WHO) last week said its global trial of COVID-